IMblaze370 evaluated atezolizumab with or without cobimetinib versus regorafenib in patients with mCRC. EC arms were constructed from the Flatiron Health (FH) EHR-derived de-identified database and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback